ConductScience.org, home
ACP3: acid phosphatase 3
API referenceFor AI assistants

Gene · 55

Papers3,704

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

1 to 20 of 3,704

Download this page as JSON
TitleJournalYearPMIDFound bySource
Vaccines for Cancer: A Translational Science Review.JAMA202642766303PubTator, text miningPubMed
Tobramycin-Peptide Nucleic Acids Synergize with Polymyxin B and Other Bioactive Compounds to Inhibit Growth of Gram-Negative Bacteria.ACS Infect Dis202642725966PubTator, text miningPubMed
Epidermotropic Metastatic Prostate Adenocarcinoma With Florid Squamous Transformation/Differentiation and Associated Acantholysis. An Unusual Clinicopathologic Entity.Case Rep Dermatol Med202642699160PubTator, text miningPubMed
Eradication of pre-clinical prostate tumors by a lentiviral vector-based immunotherapy.Mol Ther Oncol202642598525PubTator, text miningPubMed
Prostate Cancer Recurrence Mimicking a Primary Paranasal Sinus Tumor on 18F-FDG PET/CT During Treatment for Metastases After 10 Years of Remission.Case Rep Radiol202642569055PubTator, text miningPubMed
Prostatic Acid Phosphatase (PAP) Antibodies to Treat Castration-Resistant Prostate Cancer.Int J Mol Sci202642511478PubTator, text miningPubMed
ACP3-targeted PET imaging agents based on small-molecule ligands for prostate cancer diagnostics and theranostics.Am J Nucl Med Mol Imaging202642495193PubTator, text miningPubMed
Transcriptome analysis of follicular granulosa cells in young women with diminished ovarian reserve.Reprod Biol Endocrinol202642458461PubTator, text miningPubMed
Prostate Cancer: Etiology, Diagnosis, and Treatment.Serican J Med202642375929PubTator, text miningPubMed
Atypical Presentation of Metastatic Prostate Adenocarcinoma in the Presacral Space: A Case Report of Diagnostic Resection via the Kraske Approach.Am Surg202642360889PubTator, text miningPubMed
Extracellular polysaccharide-facilitated selenium nanoparticle assembly and metabolic reprogramming support efficient selenite biotransformation by ARTP-mutagenized Lactiplantibacillus plantarum Vse252.
Bioresour Technol202642331187PubTator, text miningPubMed
Overall Survival of Patients With PSA-Recurrent Prostate Cancer: Long-Term Analysis of a Randomized Phase 2 Trial of pTVG-HP DNA Vaccine Versus Placebo.Clin Genitourin Cancer202642303538PubTator, text miningPubMed
A Novel Drug Candidate that Selectively Targets the Critical Androgen Receptor-ELK1 Growth Axis in Advanced and Drug-Resistant Prostate Cancer.bioRxiv202642272933PubTator, text miningPubMed
Prostatic acid phosphatase: a rediscovered target in prostate cancer.Nat Rev Urol202642174222PubTator, text miningPubMed
De novo acyl carrier proteins display structure-independent modification and sequence novelty.RSC Chem Biol202642124780PubTator, text miningPubMed
Dynamics, Pharmacokinetics, and Dosimetry of First-in-Human [68Ga]Ga-OncoACP3-DOTA PET in Patients with Prostate Cancer.J Nucl Med202642061944PubTator, text miningPubMed
De novo acyl carrier proteins display structure-independent modification and sequence novelty.bioRxiv202642039432PubTator, text miningPubMed
Phase 2 trial of pTVG-HP ± pTVG-AR DNA vaccines and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC).J Immunother Cancer202642031429PubTator, text miningPubMed
The prostatic acid phosphatase in prostate cancer: A novel theranostic target.Semin Nucl Med202641925410PubTator, text miningPubMed
Novel Immunotherapeutic Strategies for Castration-Resistant Prostate Cancer: Mechanisms and Clinical Advances.Curr Issues Mol Biol202641899434PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Next page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/55/papers

API referenceFor AI assistants